hemostOD
Lausanne, CH · Founded 2020 · 12 employees on LinkedIn · 2 known investors
HemostOD engineers and manufactures universal (HLA-low) platelets using a proprietary platform that immortalizes hematopoietic progenitor cells and generates platelets via microfluidic bioreactors. The preclinical biotech targets applications in thrombocytopenia, tissue-targeted cargo delivery, regenerative medicine, and therapeutic stem cell culture.
Founders & leadership
hemostOD was founded in 2020 by Faouzi Khechana.
FK
Faouzi KhechanainFounder
Investors · 2
Frequently asked questions
- What does hemostOD do?
- HemostOD engineers and manufactures universal (HLA-low) platelets using a proprietary platform that immortalizes hematopoietic progenitor cells and generates platelets via microfluidic bioreactors. The preclinical biotech targets applications in thrombocytopenia, tissue-targeted cargo delivery, regenerative medicine, and therapeutic stem cell culture.
- Who founded hemostOD?
- hemostOD was founded by Faouzi Khechana in 2020.
- Who are hemostOD's investors?
- hemostOD's investors include Polytech Ventures, Polytech Ecosystem Ventures.
- Where is hemostOD headquartered?
- hemostOD is headquartered in Lausanne, CH.